Connection

Adrian Van Bakel to Cardiovascular Agents

Back to Details
This is a "connection" page, showing publications Adrian Van Bakel has written about Cardiovascular Agents.
Adrian Van Bakel
Connection Strength
0.138
Cardiovascular Agents
  1. A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction. Eur J Heart Fail. 2017 10; 19(10):1321-1332.
    View in: PubMed
    Score: 0.138
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.